Onconova Therapeutics (NASDAQ:ONTX) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Rating) in a research note released on Thursday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright upgraded shares of Onconova Therapeutics from a neutral rating to a buy rating and set a $11.00 target price for the company […]

Related Keywords

Ramesh Kumar ,E Premkumar Reddy ,Vanguard Group Inc ,Onconova Therapeutics Company Profile ,Millennium Management ,Renaissance Technologies ,Beacon Pointe Advisors ,Onconova Therapeutics Inc ,Onconova Therapeutics ,Get Rating ,Therapeutics Trading Down ,Pointe Advisors ,Vanguard Group ,Onconova Therapeutics Daily ,Nasdaq Ontx ,Contx ,Medical ,Initiated Coverage ,Stocknews Com ,